부산대학교 도서관

Kulp, Daniel W ; Schief, William R

In Current Opinion in Virology June 2013 3(3):322-331

Romanov A; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Knappe GA; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.; Ronsard L; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Cottrell CA; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; IAVI Antibody Neutralizing Center, The Scripps Research Institute, La Jolla, CA, USA.; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.; Zhang YJ; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Suh H; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; Duhamel L; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Omer M; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.; Department of Biomedicine, Aarhus University, Aarhus, Denmark.; Chapman AP; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; Spivakovsky K; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.; Skog P; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; IAVI Antibody Neutralizing Center, The Scripps Research Institute, La Jolla, CA, USA.; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.; Flynn CT; IAVI Antibody Neutralizing Center, The Scripps Research Institute, La Jolla, CA, USA.; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.; Lee JH; IAVI Antibody Neutralizing Center, The Scripps Research Institute, La Jolla, CA, USA.; Kalyuzhniy O; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; IAVI Antibody Neutralizing Center, The Scripps Research Institute, La Jolla, CA, USA.; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.; Liguori A; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; IAVI Antibody Neutralizing Center, The Scripps Research Institute, La Jolla, CA, USA.; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.; Parsons MF; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.; Lewis VR; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Canales J; Department of Pathology, New York University Grossman School of Medicine, New York, NY, USA.; Reizis B; Department of Pathology, New York University Grossman School of Medicine, New York, NY, USA.; Tingle RD; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; IAVI Antibody Neutralizing Center, The Scripps Research Institute, La Jolla, CA, USA.; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.; Schiffner T; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; IAVI Antibody Neutralizing Center, The Scripps Research Institute, La Jolla, CA, USA.; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.; Schief WR; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; IAVI Antibody Neutralizing Center, The Scripps Research Institute, La Jolla, CA, USA.; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.; Moderna, Inc., Cambridge, MA, USA.; Lingwood D; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Bathe M; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Harvard Medical School Initiative for RNA Medicine, Harvard Medical School, Boston, MA, USA.; Irvine DJ; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.; Howard Hughes Medical Institute, The Scripps Research Institute, La Jolla, CA, USA.

Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-9203 (Electronic) Linking ISSN: 00368075 NLM ISO Abbreviation: Science Subsets: MEDLINE

Sutton HJ; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA 92037, USA.; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; Ma KM; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Steichen JM; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Schiffner T; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Altheide TK; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA 92037, USA.; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; Liguori A; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Lu D; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Kubitz M; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Georgeson E; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Phelps N; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Tingle R; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Alavi NB; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Ben-Akiva E; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Zhou X; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Kifude C; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Flynn CT; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Rakasz E; Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI 53715, USA.; Irvine DJ; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA.; Schief WR; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Moderna Inc., Cambridge, MA 02142, USA.; Crotty S; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA 92037, USA.; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego (UCSD), La Jolla, CA 92037, USA.

Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101688624 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2470-9468 (Electronic) Linking ISSN: 24709468 NLM ISO Abbreviation: Sci Immunol Subsets: MEDLINE

Xie Z; Batista Lab, Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA 02139, USA.; Wang X; Batista Lab, Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA 02139, USA.; Yan Y; Batista Lab, Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA 02139, USA.; Steichen JM; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; International AIDS Vaccine Initiative (IAVI) Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Center for HIV/AIDS Vaccine Development, Scripps Research Institute, La Jolla, CA 92037, USA.; Ma KM; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; International AIDS Vaccine Initiative (IAVI) Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Center for HIV/AIDS Vaccine Development, Scripps Research Institute, La Jolla, CA 92037, USA.; Cottrell CA; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; International AIDS Vaccine Initiative (IAVI) Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Center for HIV/AIDS Vaccine Development, Scripps Research Institute, La Jolla, CA 92037, USA.; Melzi E; Batista Lab, Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA 02139, USA.; Bottermann M; Batista Lab, Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA 02139, USA.; Villavicencio PM; Batista Lab, Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA 02139, USA.; Rantalainen K; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; International AIDS Vaccine Initiative (IAVI) Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Center for HIV/AIDS Vaccine Development, Scripps Research Institute, La Jolla, CA 92037, USA.; Schiffner T; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; International AIDS Vaccine Initiative (IAVI) Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Center for HIV/AIDS Vaccine Development, Scripps Research Institute, La Jolla, CA 92037, USA.; Institute for Drug Discovery, Leipzig University Medical Faculty, Leipzig, 04103, Germany.; Warner JE; Batista Lab, Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA 02139, USA.; Weldon SR; Batista Lab, Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA 02139, USA.; Prum T; Batista Lab, Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA 02139, USA.; Ellis-Pugh JR; Batista Lab, Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA 02139, USA.; Torres JL; Department of Integrative Structural and Computational Biology, Scripps Research Institute, La Jolla, CA 92037, USA.; Jackson AM; Department of Integrative Structural and Computational Biology, Scripps Research Institute, La Jolla, CA 92037, USA.; Flynn CT; International AIDS Vaccine Initiative (IAVI) Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Ozorowski G; Center for HIV/AIDS Vaccine Development, Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Integrative Structural and Computational Biology, Scripps Research Institute, La Jolla, CA 92037, USA.; Himansu S; Moderna Inc., Cambridge, MA 02142, USA.; Carfi A; Moderna Inc., Cambridge, MA 02142, USA.; Ward AB; Center for HIV/AIDS Vaccine Development, Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Integrative Structural and Computational Biology, Scripps Research Institute, La Jolla, CA 92037, USA.; Nair U; Batista Lab, Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA 02139, USA.; Schief WR; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; International AIDS Vaccine Initiative (IAVI) Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Center for HIV/AIDS Vaccine Development, Scripps Research Institute, La Jolla, CA 92037, USA.; Moderna Inc., Cambridge, MA 02142, USA.; Batista FD; Batista Lab, Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA 02139, USA.; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Department of Immunology, Harvard Medical School, Boston, MA 02115, USA.

Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101688624 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2470-9468 (Electronic) Linking ISSN: 24709468 NLM ISO Abbreviation: Sci Immunol Subsets: MEDLINE

Ma KM; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; Sutton HJ; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA 92037, USA.; Pratap PP; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Integrative Structural and Computational Biology, Scripps Research Institute, La Jolla, CA 92037, USA.; Steichen JM; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; Carnathan D; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; Division of Microbiology and Immunology, Emory National Primate Research Center, Emory University, Atlanta, GA 30329, USA.; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30329, USA.; Quinn J; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA 92037, USA.; Kalyuzhniy O; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; Liguori A; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; Agrawal S; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Integrative Structural and Computational Biology, Scripps Research Institute, La Jolla, CA 92037, USA.; Baboo S; Department of Molecular Medicine, Scripps Research Institute, La Jolla, CA 92037, USA.; Madden P; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA 92037, USA.; Cottrell CA; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; Willis JR; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; Lee JH; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; Landais E; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; Hu X; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; Ramezani-Rad P; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA 92037, USA.; Ozorowski G; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Integrative Structural and Computational Biology, Scripps Research Institute, La Jolla, CA 92037, USA.; Lewis VR; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; Division of Microbiology and Immunology, Emory National Primate Research Center, Emory University, Atlanta, GA 30329, USA.; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30329, USA.; Diedrich JK; Department of Molecular Medicine, Scripps Research Institute, La Jolla, CA 92037, USA.; Zhou X; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; Altheide TK; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA 92037, USA.; Phelps N; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; Georgeson E; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; Alavi NB; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; Lu D; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; Eskandarzadeh S; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; Kubitz M; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; Adachi Y; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; Mullen TM; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; Silva M; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; Melo MB; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA.; Himansu S; Moderna Inc., Cambridge, MA 02139, USA.; Irvine DJ; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA.; David H. Koch Institute for Integrative Cancer Research, MIT, Cambridge, MA 02139, USA.; Department of Materials Science and Engineering, MIT, Cambridge, MA 02139, USA.; Department of Biological Engineering, MIT, Cambridge, MA 02139, USA.; Ragon Institute of Massachusetts General Hospital, Cambridge, MA 02139, USA.; Burton DR; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; Yates JR 3rd; Department of Molecular Medicine, Scripps Research Institute, La Jolla, CA 92037, USA.; Paulson JC; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Molecular Medicine, Scripps Research Institute, La Jolla, CA 92037, USA.; Sok D; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Wilson IA; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Integrative Structural and Computational Biology, Scripps Research Institute, La Jolla, CA 92037, USA.; Silvestri G; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; Division of Microbiology and Immunology, Emory National Primate Research Center, Emory University, Atlanta, GA 30329, USA.; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30329, USA.; Ward AB; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Integrative Structural and Computational Biology, Scripps Research Institute, La Jolla, CA 92037, USA.; Crotty S; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA 92037, USA.; Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego (UCSD), La Jolla, CA, 92037 USA.; Schief WR; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; Moderna Inc., Cambridge, MA 02139, USA.

Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101688624 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2470-9468 (Electronic) Linking ISSN: 24709468 NLM ISO Abbreviation: Sci Immunol Subsets: MEDLINE

Willis JR; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA, USA.; Prabhakaran M; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.; Muthui M; Kenya Medical Research Institute - Wellcome Trust Research Programme, Kilifi, Kenya.; Naidoo A; IAVI, New York, NY, USA.; Sincomb T; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA, USA.; Wu W; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.; Cottrell CA; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA, USA.; Landais E; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA, USA.; deCamp AC; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Keshavarzi NR; IAVI, New York, NY, USA.; Kalyuzhniy O; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA, USA.; Lee JH; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA, USA.; Murungi LM; IAVI, Nairobi, Kenya.; Ogonda WA; Kenya Medical Research Institute - Wellcome Trust Research Programme, Kilifi, Kenya.; Yates NL; Center for Human Systems Immunology, Departments of Surgery, Immunology, Molecular Genetics and Microbiology, Duke University, Durham, NC, USA.; Corcoran MM; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.; Phulera S; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA, USA.; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.; Musando J; KAVI - Institute of Clinical Research, University of Nairobi, Nairobi, Kenya.; Tsai A; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Lemire G; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Sein Y; Kenya Medical Research Institute - Wellcome Trust Research Programme, Kilifi, Kenya.; Muteti M; Kenya Medical Research Institute - Wellcome Trust Research Programme, Kilifi, Kenya.; Alamuri P; IAVI, New York, NY, USA.; Bohl JA; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.; Holman D; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Himansu S; Moderna, Cambridge, MA, USA.; Leav B; Moderna, Cambridge, MA, USA.; Reuter C; Moderna, Cambridge, MA, USA.; Lin LA; Moderna, Cambridge, MA, USA.; Ding B; Moderna, Cambridge, MA, USA.; He C; Moderna, Cambridge, MA, USA.; Straus WL; Moderna, Cambridge, MA, USA.; MacPhee KJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Regadas I; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.; Nyabundi DV; Kenya Medical Research Institute - Wellcome Trust Research Programme, Kilifi, Kenya.; Chirchir R; KAVI - Institute of Clinical Research, University of Nairobi, Nairobi, Kenya.; Anzala O; KAVI - Institute of Clinical Research, University of Nairobi, Nairobi, Kenya.; Kimotho JN; Kenya Medical Research Institute - Wellcome Trust Research Programme, Kilifi, Kenya.; Kibet C; Center for Human Systems Immunology, Departments of Surgery, Immunology, Molecular Genetics and Microbiology, Duke University, Durham, NC, USA.; Greene K; Duke University Medical Center, Durham, NC, USA.; Gao H; Duke University Medical Center, Durham, NC, USA.; Beatman E; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Benson K; IAVI, New York, NY, USA.; Laddy D; IAVI, New York, NY, USA.; Brown DM; The Foundation for the National Institutes of Health, North Bethesda, MD, USA.; Bronson R; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.; Jean-Baptiste J; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.; Gajjala S; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.; Rikhtegaran-Tehrani Z; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.; Benner A; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.; Ramaswami M; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.; Lu D; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA, USA.; Alavi N; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA, USA.; Amirzehni S; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA, USA.; Kubitz M; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA, USA.; Tingle R; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA, USA.; Georgeson E; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA, USA.; Phelps N; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA, USA.; Adachi Y; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA, USA.; Liguori A; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA, USA.; Flynn C; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA, USA.; McKenney K; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA, USA.; Zhou X; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA, USA.; Owuor DC; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.; Owuor SA; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.; Kim SY; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Duff M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Kim JY; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Gibson G; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.; Baboo S; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.; Diedrich J; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.; Schiffner T; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA, USA.; Shields M; IAVI, New York, NY, USA.; Matsoso M; IAVI, New York, NY, USA.; Santos J; IAVI, New York, NY, USA.; Syvertsen K; IAVI, New York, NY, USA.; Kennedy A; IAVI, New York, NY, USA.; Schroeter M; IAVI, New York, NY, USA.; Vekemans J; IAVI, New York, NY, USA.; Yates JR 3rd; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.; Paulson JC; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA, USA.; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA, USA.; Hyrien O; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; McDermott AB; Vaccines Research and Development, Sanofi, Swiftwater, PA, USA.; Maenetje P; The Aurum Institute, Rustenburg Research Centre, Rustenburg, South Africa.; Nyombayire J; Center For Family Health Research, Kicukiro, Kigali, Rwanda.; Karita E; Center For Family Health Research, Kicukiro, Kigali, Rwanda.; Ingabire R; Center For Family Health Research, Kicukiro, Kigali, Rwanda.; Edward V; The Aurum Institute, Rustenburg Research Centre, Rustenburg, South Africa.; Department of Medicine, Vanderbilt University, Nashville, TN, USA.; School of Health Sciences, College of Health Sciences, Westville Campus, University of KwaZulu-Natal, Durban, South Africa.; Muturi-Kioi V; IAVI, Nairobi, Kenya.; Maenza J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Department of Medicine, University of Washington, Seattle, WA, USA.; Shapiro AE; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Department of Medicine, University of Washington, Seattle, WA, USA.; McElrath MJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Department of Medicine, University of Washington, Seattle, WA, USA.; Edupuganti S; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.; Taylor BS; Division of Infectious Diseases, Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas.; Diemert D; Department of Microbiology, Immunology and Tropical Medicine, School of Medicine and Health Sciences, The George Washington University, Washington, DC, USA.; Department of Medicine, School of Medicine and Health Sciences, The George Washington University, Washington, DC, USA.; Ozorowski G; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA, USA.; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.; Koup RA; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.; Montefiori D; Duke University Medical Center, Durham, NC, USA.; Ward AB; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA, USA.; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.; Karlsson Hedestam GB; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.; Tomaras G; Center for Human Systems Immunology, Departments of Surgery, Immunology, Molecular Genetics and Microbiology, Duke University, Durham, NC, USA.; Hunt DJ; IAVI, New York, NY, USA.; Muema D; KAVI - Institute of Clinical Research, University of Nairobi, Nairobi, Kenya.; Sok D; IAVI, New York, NY, USA.; Laufer DS; IAVI, New York, NY, USA.; Andrews SF; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.; Nduati EW; Kenya Medical Research Institute - Wellcome Trust Research Programme, Kilifi, Kenya.; Schief WR; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.; Center for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA, USA.; Moderna, Cambridge, MA, USA.

Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-9203 (Electronic) Linking ISSN: 00368075 NLM ISO Abbreviation: Science Subsets: MEDLINE

Parks KR; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Moodie Z; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Allen MA; Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD 20852, USA.; Yen C; Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD 20852, USA.; Furch BD; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; MacPhee KJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Ozorowski G; Department of Integrative, Structural, and Computational Biology, Scripps Research Institute, La Jolla, CA 92037, USA.; Heptinstall J; Center for Human Systems Immunology, Departments of Surgery, Immunology, Molecular Genetics, and Microbiology, Duke University, Durham, NC 27701, USA.; Hahn WO; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Department of Medicine, University of Washington, Seattle, WA 98195, USA.; Zheng Z; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Lu H; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Grant S; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Domin E; Duke University Medical Center, Durham, NC 27701, USA.; Duff MO; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Seese A; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Marini-Macouzet C; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Ballweber-Fleming L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Lee WH; Department of Integrative, Structural, and Computational Biology, Scripps Research Institute, La Jolla, CA 92037, USA.; Cottrell CA; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, Scripps Research Institute, La Jolla, CA 92037 USA.; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; Liguori A; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, Scripps Research Institute, La Jolla, CA 92037 USA.; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Georgeson E; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, Scripps Research Institute, La Jolla, CA 92037 USA.; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Alavi N; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, Scripps Research Institute, La Jolla, CA 92037 USA.; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Kubitz M; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, Scripps Research Institute, La Jolla, CA 92037 USA.; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Phelps N; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, Scripps Research Institute, La Jolla, CA 92037 USA.; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Seaton KE; Center for Human Systems Immunology, Departments of Surgery, Immunology, Molecular Genetics, and Microbiology, Duke University, Durham, NC 27701, USA.; Cohen KW; Moderna, 325 Binney Street, Cambridge, MA 02142, USA.; Anderson MA; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Mondal K; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Laufer DS; IAVI, New York, NY 10004, USA.; Kublin JG; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Ward AB; Department of Integrative, Structural, and Computational Biology, Scripps Research Institute, La Jolla, CA 92037, USA.; Hyrien O; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Department of Biostatistics, University of Washington, Seattle, WA 98195, USA.; De Rosa SC; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195, USA.; Himansu S; Moderna, 325 Binney Street, Cambridge, MA 02142, USA.; Leav B; Moderna, 325 Binney Street, Cambridge, MA 02142, USA.; Reuter C; Moderna, 325 Binney Street, Cambridge, MA 02142, USA.; Tomaras GD; Center for Human Systems Immunology, Departments of Surgery, Immunology, Molecular Genetics, and Microbiology, Duke University, Durham, NC 27701, USA.; Montefiori D; Duke University Medical Center, Durham, NC 27701, USA.; Walsh SR; Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.; Frank I; Division of Infectious Diseases, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.; Sobieszczyk ME; Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, NY 10032, USA.; Goepfert PA; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35205, USA.; Stephenson KE; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.; Baden LR; Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.; Van Tieu H; New York Blood Center, New York, NY 10017, USA.; Keefer MC; Infectious Diseases Division, Department of Medicine, University of Rochester, Rochester, NY 14627, USA.; Clark J; Department of Medicine, Division of Infectious Diseases, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA 90095, USA.; Riddler SA; Division of Infectious Diseases, Department of Medicine, University of Pittsburgh, Pittsburgh, PA 15213, USA.; Schief WR; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, Scripps Research Institute, La Jolla, CA 92037 USA.; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Moderna, 325 Binney Street, Cambridge, MA 02142, USA.; McElrath MJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Department of Medicine, University of Washington, Seattle, WA 98195, USA.

Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE

Ramezani-Rad P; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA 92037, USA.; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; Cottrell CA; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; Marina-Zárate E; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA 92037, USA.; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; Liguori A; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, San Diego, CA 92121, USA.; Landais E; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, San Diego, CA 92121, USA.; Torres JL; Department of Integrative Structural and Computational Biology, Scripps Research Institute, La Jolla, CA 92037, USA.; Myers A; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA 92037, USA.; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; Lee JH; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, San Diego, CA 92121, USA.; Baboo S; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Molecular Medicine, Scripps Research Institute, La Jolla, CA 92037, USA.; Flynn C; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, San Diego, CA 92121, USA.; McKenney K; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, San Diego, CA 92121, USA.; Salcedo E; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, San Diego, CA 92121, USA.; Zhou X; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, San Diego, CA 92121, USA.; Kalyuzhniy O; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, San Diego, CA 92121, USA.; Georgeson E; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; Phelps N; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; Lu D; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; Eskandarzadeh S; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; Menis S; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, San Diego, CA 92121, USA.; Kubitz M; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; Groschel B; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, San Diego, CA 92121, USA.; Alavi N; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; Jackson AM; Department of Integrative Structural and Computational Biology, Scripps Research Institute, La Jolla, CA 92037, USA.; Lee WH; Department of Integrative Structural and Computational Biology, Scripps Research Institute, La Jolla, CA 92037, USA.; Tran AS; Department of Integrative Structural and Computational Biology, Scripps Research Institute, La Jolla, CA 92037, USA.; Ben-Akiva E; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Kaczmarek Michaels K; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Diedrich JK; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Molecular Medicine, Scripps Research Institute, La Jolla, CA 92037, USA.; Enemuo CA; Emory National Primate Research Center and Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA 30329, USA.; Lewis V; Emory National Primate Research Center and Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA 30329, USA.; Pradhan A; Emory National Primate Research Center and Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA 30329, USA.; Kasturi SP; Emory National Primate Research Center and Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA 30329, USA.; Schiffner T; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, San Diego, CA 92121, USA.; Steichen JM; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, San Diego, CA 92121, USA.; Carnathan DG; Emory National Primate Research Center and Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA 30329, USA.; Himansu S; Moderna Inc., Cambridge, MA 02142, USA.; Yates JR 3rd; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Molecular Medicine, Scripps Research Institute, La Jolla, CA 92037, USA.; Paulson JC; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Molecular Medicine, Scripps Research Institute, La Jolla, CA 92037, USA.; Ozorowski G; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, San Diego, CA 92121, USA.; Department of Integrative Structural and Computational Biology, Scripps Research Institute, La Jolla, CA 92037, USA.; Irvine DJ; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA.; Silvestri G; Emory National Primate Research Center and Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA 30329, USA.; Sok D; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, San Diego, CA 92121, USA.; Ward AB; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, San Diego, CA 92121, USA.; Department of Integrative Structural and Computational Biology, Scripps Research Institute, La Jolla, CA 92037, USA.; Crotty S; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA 92037, USA.; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego (UCSD), La Jolla, CA 92037, USA.; Schief WR; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, San Diego, CA 92121, USA.; Moderna Inc., Cambridge, MA 02142, USA.

Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE

Yan Y; Batista Laboratory, Ragon Institute of Mass General Brigham, MIT, and Harvard, Cambridge, MA 02139, USA.; Wang X; Batista Laboratory, Ragon Institute of Mass General Brigham, MIT, and Harvard, Cambridge, MA 02139, USA.; Xie Z; Batista Laboratory, Ragon Institute of Mass General Brigham, MIT, and Harvard, Cambridge, MA 02139, USA.; Bader DLV; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA 92037, USA; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA.; Lim RH; Liu Laboratory, Ragon Institute of Mass General Brigham, MIT, and Harvard, Cambridge, MA 02139, USA; Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Ma KM; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA 92037, USA; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA.; Cottrell CA; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA 92037, USA; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA.; Steichen JM; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA 92037, USA; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA.; Xu L; Batista Laboratory, Ragon Institute of Mass General Brigham, MIT, and Harvard, Cambridge, MA 02139, USA.; Villavicencio PM; Batista Laboratory, Ragon Institute of Mass General Brigham, MIT, and Harvard, Cambridge, MA 02139, USA.; Akauliya M; Batista Laboratory, Ragon Institute of Mass General Brigham, MIT, and Harvard, Cambridge, MA 02139, USA.; Koo JH; Batista Laboratory, Ragon Institute of Mass General Brigham, MIT, and Harvard, Cambridge, MA 02139, USA.; Shen JM; Batista Laboratory, Ragon Institute of Mass General Brigham, MIT, and Harvard, Cambridge, MA 02139, USA; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Vernich A; Liu Laboratory, Ragon Institute of Mass General Brigham, MIT, and Harvard, Cambridge, MA 02139, USA.; Kalyuzhniy O; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA 92037, USA; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA.; Allen JD; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA 92037, USA; School of Biological Sciences, University of Southampton, Southampton SO17 1BJ, UK.; Albowaidey AA; Batista Laboratory, Ragon Institute of Mass General Brigham, MIT, and Harvard, Cambridge, MA 02139, USA.; Alicea A; Batista Laboratory, Ragon Institute of Mass General Brigham, MIT, and Harvard, Cambridge, MA 02139, USA.; Chen B; Batista Laboratory, Ragon Institute of Mass General Brigham, MIT, and Harvard, Cambridge, MA 02139, USA; Liu Laboratory, Ragon Institute of Mass General Brigham, MIT, and Harvard, Cambridge, MA 02139, USA.; Georgeson E; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA 92037, USA; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA.; Ellis-Pugh JR; Batista Laboratory, Ragon Institute of Mass General Brigham, MIT, and Harvard, Cambridge, MA 02139, USA.; Alavi N; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA 92037, USA; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA.; Esposito A; Batista Laboratory, Ragon Institute of Mass General Brigham, MIT, and Harvard, Cambridge, MA 02139, USA.; Naili H; Batista Laboratory, Ragon Institute of Mass General Brigham, MIT, and Harvard, Cambridge, MA 02139, USA.; Phelps N; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA 92037, USA; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA.; Kelley B; Batista Laboratory, Ragon Institute of Mass General Brigham, MIT, and Harvard, Cambridge, MA 02139, USA.; Kubitz M; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA 92037, USA; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA.; Phan QA; Batista Laboratory, Ragon Institute of Mass General Brigham, MIT, and Harvard, Cambridge, MA 02139, USA.; Liguori A; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA 92037, USA; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA.; Prum T; Batista Laboratory, Ragon Institute of Mass General Brigham, MIT, and Harvard, Cambridge, MA 02139, USA.; Tingle R; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA 92037, USA; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA.; Lu D; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA 92037, USA; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA.; Eskandarzadeh S; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA 92037, USA; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA.; Liu X; Batista Laboratory, Ragon Institute of Mass General Brigham, MIT, and Harvard, Cambridge, MA 02139, USA.; Warner JE; Batista Laboratory, Ragon Institute of Mass General Brigham, MIT, and Harvard, Cambridge, MA 02139, USA.; Weldon SR; Batista Laboratory, Ragon Institute of Mass General Brigham, MIT, and Harvard, Cambridge, MA 02139, USA.; Himansu S; Moderna, Cambridge, MA 02142, USA.; Crispin M; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA 92037, USA; School of Biological Sciences, University of Southampton, Southampton SO17 1BJ, UK.; Nair U; Batista Laboratory, Ragon Institute of Mass General Brigham, MIT, and Harvard, Cambridge, MA 02139, USA.; Liu S; Liu Laboratory, Ragon Institute of Mass General Brigham, MIT, and Harvard, Cambridge, MA 02139, USA. Electronic address: sophia.liu@mgh.harvard.edu.; Schief WR; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA 92037, USA; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA; Moderna, Cambridge, MA 02142, USA. Electronic address: schief@scripps.edu.; Batista FD; Batista Laboratory, Ragon Institute of Mass General Brigham, MIT, and Harvard, Cambridge, MA 02139, USA; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Department of Immunology, Harvard Medical School, Boston, MA 02115, USA. Electronic address: fbatista1@mgh.harvard.edu.

Publisher: Cell Press Country of Publication: United States NLM ID: 9432918 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-4180 (Electronic) Linking ISSN: 10747613 NLM ISO Abbreviation: Immunity Subsets: MEDLINE

Rantalainen K; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.; Liguori A; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.; Ozorowski G; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.; Flynn C; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.; Steichen JM; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.; Swanson OM; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.; Madden PJ; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA, USA.; Baboo S; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.; Phulera S; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.; Gharpure A; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.; Lu D; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.; Kalyuzhniy O; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.; Skog P; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.; Terada S; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.; Shil M; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA, USA.; Diedrich JK; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.; Georgeson E; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.; Tingle R; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.; Eskandarzadeh S; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.; Lee WH; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.; Alavi N; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.; Goodwin D; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.; Kubitz M; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.; Amirzehni S; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.; Himansu S; Moderna Inc., Cambridge, MA, USA.; Sok D; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.; Lee JH; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.; Yates JR 3rd; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.; Paulson JC; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.; Crotty S; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA, USA.; Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego (UCSD), La Jolla, CA, USA.; Schiffner T; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA. torbens@scripps.edu.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA. torbens@scripps.edu.; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA. torbens@scripps.edu.; Institute for Drug Discovery, Leipzig University Medical Faculty, Leipzig, Germany. torbens@scripps.edu.; Ward AB; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA. andrew@scripps.edu.; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA. andrew@scripps.edu.; Schief WR; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA. schief@scripps.edu.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA. schief@scripps.edu.; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA. schief@scripps.edu.; Moderna Inc., Cambridge, MA, USA. schief@scripps.edu.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Huang J; Department of Integrative Structural and Computational Biology, the Scripps Research Institute, La Jolla, CA, USA.; Swanson OM; Department of Integrative Structural and Computational Biology, the Scripps Research Institute, La Jolla, CA, USA; Department of Immunology and Microbiology, the Scripps Research Institute, La Jolla, CA, USA; Consortia for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVD), the Scripps Research Institute, La Jolla, CA, USA; IAVI Neutralizing Antibody Center, the Scripps Research Institute, La Jolla, CA, USA.; Rantalainen K; Department of Immunology and Microbiology, the Scripps Research Institute, La Jolla, CA, USA; Consortia for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVD), the Scripps Research Institute, La Jolla, CA, USA; IAVI Neutralizing Antibody Center, the Scripps Research Institute, La Jolla, CA, USA.; Fernández-Quintero ML; Department of Integrative Structural and Computational Biology, the Scripps Research Institute, La Jolla, CA, USA.; Loeffler JR; Department of Integrative Structural and Computational Biology, the Scripps Research Institute, La Jolla, CA, USA.; Tingle R; Department of Immunology and Microbiology, the Scripps Research Institute, La Jolla, CA, USA; Consortia for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVD), the Scripps Research Institute, La Jolla, CA, USA; IAVI Neutralizing Antibody Center, the Scripps Research Institute, La Jolla, CA, USA.; Georgeson E; Department of Immunology and Microbiology, the Scripps Research Institute, La Jolla, CA, USA; Consortia for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVD), the Scripps Research Institute, La Jolla, CA, USA; IAVI Neutralizing Antibody Center, the Scripps Research Institute, La Jolla, CA, USA.; Phelps N; Department of Immunology and Microbiology, the Scripps Research Institute, La Jolla, CA, USA; Consortia for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVD), the Scripps Research Institute, La Jolla, CA, USA; IAVI Neutralizing Antibody Center, the Scripps Research Institute, La Jolla, CA, USA.; Ozorowski G; Department of Integrative Structural and Computational Biology, the Scripps Research Institute, La Jolla, CA, USA; Consortia for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVD), the Scripps Research Institute, La Jolla, CA, USA; IAVI Neutralizing Antibody Center, the Scripps Research Institute, La Jolla, CA, USA.; Schiffner T; Department of Immunology and Microbiology, the Scripps Research Institute, La Jolla, CA, USA; Consortia for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVD), the Scripps Research Institute, La Jolla, CA, USA; IAVI Neutralizing Antibody Center, the Scripps Research Institute, La Jolla, CA, USA.; Schief WR; Department of Immunology and Microbiology, the Scripps Research Institute, La Jolla, CA, USA; Consortia for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVD), the Scripps Research Institute, La Jolla, CA, USA; IAVI Neutralizing Antibody Center, the Scripps Research Institute, La Jolla, CA, USA; Moderna, Inc., Cambridge, MA, USA. Electronic address: schief@scripps.edu.; Ward AB; Department of Integrative Structural and Computational Biology, the Scripps Research Institute, La Jolla, CA, USA; Consortia for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVD), the Scripps Research Institute, La Jolla, CA, USA; IAVI Neutralizing Antibody Center, the Scripps Research Institute, La Jolla, CA, USA. Electronic address: andrew@scripps.edu.

Publisher: Cell Press Country of Publication: United States NLM ID: 101573691 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-1247 (Electronic) NLM ISO Abbreviation: Cell Rep Subsets: MEDLINE

Peres A; Department of Pathology, Yale School of Medicine, New Haven, CT 06250, USA; Faculty of Engineering, Bar Ilan University, Ramat Gan, Israel; Bar Ilan institute of Nanotechnology and Advanced Materials, Bar Ilan University, Ramat Gan, Israel.; Upadhyay AA; Emory National Primate Research Center, Atlanta, GA 30329, USA; Department of Pathology & Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA.; Klein V; Faculty of Engineering, Bar Ilan University, Ramat Gan, Israel; Bar Ilan institute of Nanotechnology and Advanced Materials, Bar Ilan University, Ramat Gan, Israel.; Saha S; Department of Biochemistry and Molecular Genetics, University of Louisville, Louisville, KY 40292, USA.; Rodriguez OL; Department of Biochemistry and Molecular Genetics, University of Louisville, Louisville, KY 40292, USA.; Vanwinkle ZM; Emory National Primate Research Center, Atlanta, GA 30329, USA.; Karunakaran K; Emory National Primate Research Center, Atlanta, GA 30329, USA.; Metz A; Emory National Primate Research Center, Atlanta, GA 30329, USA.; Lauer W; Department of Biochemistry and Molecular Genetics, University of Louisville, Louisville, KY 40292, USA.; Lin MC; Emory National Primate Research Center, Atlanta, GA 30329, USA.; Melton T; Emory National Primate Research Center, Atlanta, GA 30329, USA.; Granholm L; Emory National Primate Research Center, Atlanta, GA 30329, USA.; Polak P; Faculty of Engineering, Bar Ilan University, Ramat Gan, Israel.; Peterson SM; Division of Genetics, Oregon National Primate Research Center, Beaverton, OR 97006, USA.; Peterson EJ; Wisconsin National Primate Research Center, Madison, WI 53175, USA.; Raju N; Emory National Primate Research Center, Atlanta, GA 30329, USA.; Shields K; Department of Biochemistry and Molecular Genetics, University of Louisville, Louisville, KY 40292, USA.; Schultze S; Department of Biochemistry and Molecular Genetics, University of Louisville, Louisville, KY 40292, USA.; Ton T; Emory National Primate Research Center, Atlanta, GA 30329, USA.; Ericsen AJ; Emory National Primate Research Center, Atlanta, GA 30329, USA.; Lapp SA; Emory National Primate Research Center, Atlanta, GA 30329, USA.; Villinger F; New Iberia Research Center, University of Louisiana at Lafayette, Lafayette, LA 70562, USA.; Ohlin M; Department of Immunotechnology, Lund University, Lund, Sweden; SciLifeLab, Lund University, Lund, Sweden.; Cottrell CA; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA 92037, USA; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA 92037, USA.; Amara RR; Emory National Primate Research Center, Atlanta, GA 30329, USA; Department of Microbiology and Immunology, Emory School of Medicine, Emory University, Atlanta, GA 30322, USA.; Derdeyn CA; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195, USA; Infectious Diseases and Translational Medicine Unit, Washington National Primate Research Center, University of Washington, Seattle, WA 98195, USA.; Crotty S; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA 92037, USA; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA 92037, USA; Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego (UCSD), La Jolla, CA 92037, USA.; Schief WR; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA 92037, USA; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA 92037, USA; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA; Moderna, Inc., Cambridge, MA 02142, USA.; Karlsson Hedestam GB; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.; Smith ML; Department of Biochemistry and Molecular Genetics, University of Louisville, Louisville, KY 40292, USA.; Lees W; Faculty of Engineering, Bar Ilan University, Ramat Gan, Israel; Department of Biochemistry and Molecular Genetics, University of Louisville, Louisville, KY 40292, USA.; Watson CT; Department of Biochemistry and Molecular Genetics, University of Louisville, Louisville, KY 40292, USA. Electronic address: corey.watson@louisville.edu.; Yaari G; Department of Pathology, Yale School of Medicine, New Haven, CT 06250, USA; Faculty of Engineering, Bar Ilan University, Ramat Gan, Israel; Bar Ilan institute of Nanotechnology and Advanced Materials, Bar Ilan University, Ramat Gan, Israel. Electronic address: gur.yaari@yale.edu.; Bosinger SE; Emory National Primate Research Center, Atlanta, GA 30329, USA; Department of Pathology & Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA. Electronic address: steven.bosinger@emory.edu.

Publisher: Cell Press Country of Publication: United States NLM ID: 9432918 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-4180 (Electronic) Linking ISSN: 10747613 NLM ISO Abbreviation: Immunity Subsets: MEDLINE

Rodrigues KA; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Harvard-MIT Health Sciences and Technology Program, Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02139, USA.; Consortium for HIV/AIDS Vaccine Development, Scripps Research Institute, La Jolla, CA 92037, USA.; Zhang YJ; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02139, USA.; Consortium for HIV/AIDS Vaccine Development, Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Lam J; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Aung A; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Morgan DM; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Romanov A; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02139, USA.; Consortium for HIV/AIDS Vaccine Development, Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Maiorino L; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02139, USA.; Consortium for HIV/AIDS Vaccine Development, Scripps Research Institute, La Jolla, CA 92037, USA.; Yousefpour P; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02139, USA.; Consortium for HIV/AIDS Vaccine Development, Scripps Research Institute, La Jolla, CA 92037, USA.; Gibson G; Department of Integrative, Structural and Computational Biology, Scripps Research Institute, La Jolla, CA 92037, USA.; Ozorowski G; Department of Integrative, Structural and Computational Biology, Scripps Research Institute, La Jolla, CA 92037, USA.; Gregory JR; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02139, USA.; Consortium for HIV/AIDS Vaccine Development, Scripps Research Institute, La Jolla, CA 92037, USA.; Amlashi P; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02139, USA.; Consortium for HIV/AIDS Vaccine Development, Scripps Research Institute, La Jolla, CA 92037, USA.; Van R; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Buckley M; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02139, USA.; Consortium for HIV/AIDS Vaccine Development, Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Ward AB; Consortium for HIV/AIDS Vaccine Development, Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Integrative, Structural and Computational Biology, Scripps Research Institute, La Jolla, CA 92037, USA.; Schief WR; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02139, USA.; Consortium for HIV/AIDS Vaccine Development, Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Moderna Inc., Cambridge, MA 02139, USA.; Love JC; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02139, USA.; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Irvine DJ; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02139, USA.; Consortium for HIV/AIDS Vaccine Development, Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; Department of Materials Science and Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA.

Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE

Gasperini G; GSK, Siena, Italy.; Baylor N; Biologics Consulting, Alexandria, VA, USA.; Black S; Global Vaccine Data Network, Auckland, New Zealand.; Bloom DE; Harvard T.H. Chan School of Public Health, Boston MA, USA.; Cramer J; Coalition for Epidemic Preparedness Innovations (CEPI), London, UK.; de Lannoy G; GSK, Rixensart, Belgium.; Denoel P; GSK, Rixensart, Belgium.; Feinberg M; IAVI, New York, NY, USA.; Helleputte T; DNAlytics SA, Louvain-la-Neuve, Belgium.; Kang G; Bill and Melinda Gates Foundation (BMGF), Seattle, WA, USA.; Schief WR; Moderna Inc., Boston, MA, USA.; Department of Immunology and Microbial Science, Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA, USA.; Center for HIV/AIDS Vaccine Development, Scripps Research Institute, La Jolla, CA, USA.; Stuart L; University of Washington, Seattle, WA, USA.; Weller C; Wellcome Trust, London, UK.; Zwierzyna M; GSK, Siena, Italy.; Rappuoli R; Fondazione Biotecnopolo di Siena, Siena, Italy.

Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE

Diez, Stefan ; Schief, William R ; Howard, Jonathon

In Current Biology 19 March 2002 12(6):R203-R205

Schief, William R ; Howard, Jonathon

In Current Opinion in Cell Biology 2001 13(1):19-28

Schief, William R; Dennis, Shelli R; Frey, Wolfgang ; Vogel, Viola

In Colloids and Surfaces A: Physicochemical and Engineering Aspects 2000 171(1):75-86

Schief, William R; Edwards, Todd; Frey, Wolfgang; Koppenol, Sandy; Stayton, Patrick S ; Vogel, Viola

In Biomolecular Engineering 1999 16(1):29-38

Marina-Zárate E; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, San Diego, CA, USA; Consortium for HIV Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, San Diego, CA, USA.; Sutton HJ; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, San Diego, CA, USA; Consortium for HIV Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, San Diego, CA, USA.; Lopez PG; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, San Diego, CA, USA; Consortium for HIV Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, San Diego, CA, USA.; Altheide TK; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, San Diego, CA, USA; Consortium for HIV Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, San Diego, CA, USA.; Bick M; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, San Diego, CA, USA; Consortium for HIV Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, San Diego, CA, USA.; Burton I; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, San Diego, CA, USA; Consortium for HIV Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, San Diego, CA, USA.; Ben-Akiva E; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Kaczmarek Michaels K; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA; Consortium for HIV Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, San Diego, CA, USA.; Hyacinth K; Emory National Primate Research Center and Emory Vaccine Center, Atlanta, GA, USA.; Healy BS; Emory National Primate Research Center and Emory Vaccine Center, Atlanta, GA, USA.; Lim D; Emory National Primate Research Center and Emory Vaccine Center, Atlanta, GA, USA.; Hangartner L; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, San Diego, CA, USA; Consortium for HIV Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, San Diego, CA, USA.; Burton DR; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, San Diego, CA, USA; Consortium for HIV Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, San Diego, CA, USA; IAVI Neutralizing Antibody Center (NAC), The Scripps Research Institute, La Jolla, San Diego, CA, USA.; Carnathan DG; Consortium for HIV Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, San Diego, CA, USA; Emory National Primate Research Center and Emory Vaccine Center, Atlanta, GA, USA.; Silvestri G; Consortium for HIV Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, San Diego, CA, USA; Emory National Primate Research Center and Emory Vaccine Center, Atlanta, GA, USA.; Schief WR; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, San Diego, CA, USA; Consortium for HIV Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, San Diego, CA, USA.; Irvine DJ; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, San Diego, CA, USA; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA; Consortium for HIV Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, San Diego, CA, USA; Howard Hughes Medical Institute, Chevy Chase, MD, USA.; Crotty S; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, San Diego, CA, USA; Consortium for HIV Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, San Diego, CA, USA; Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego (UCSD), La Jolla, San Diego, CA, USA. Electronic address: shane@lji.org.

Publisher: Cell Press Country of Publication: United States NLM ID: 9432918 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-4180 (Electronic) Linking ISSN: 10747613 NLM ISO Abbreviation: Immunity Subsets: MEDLINE

Wu NR; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; Beutler N; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; Hu X; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; Moderna Inc., Cambridge, MA, USA.; Skog PD; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.; Liguori A; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.; Flores-Garcia Y; Johns Hopkins Malaria Research Institute, Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.; Maiorino L; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.; Howard Hughes Medical Institute, Chevy Chase, MD, USA.; Terada S; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.; Lu D; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.; Lai YC; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; Division of Infectious Diseases, Department of Medicine, University of California, San Diego, La Jolla, CA, USA.; Ndihokubwayo J; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; Division of Infectious Diseases, Department of Medicine, University of California, San Diego, La Jolla, CA, USA.; Schiffner T; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.; Cottrell CA; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.; Eskandarzadeh S; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.; Alavi N; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.; Kubitz M; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.; Phelps N; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.; Tingle R; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.; Hodges S; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.; Youhanna JE; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.; Amirzehni S; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.; Irvine DJ; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.; Howard Hughes Medical Institute, Chevy Chase, MD, USA.; The Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Himansu S; Moderna Inc., Cambridge, MA, USA.; Zavala F; Johns Hopkins Malaria Research Institute, Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.; Rogers TF; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA. trogers@scripps.edu.; Division of Infectious Diseases, Department of Medicine, University of California, San Diego, La Jolla, CA, USA. trogers@scripps.edu.; Burton DR; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA. burton@scripps.edu.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA. burton@scripps.edu.; The Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA. burton@scripps.edu.; Schief WR; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA. schief@scripps.edu.; Moderna Inc., Cambridge, MA, USA. schief@scripps.edu.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA. schief@scripps.edu.

Publisher: Springer Nature in partnership with the Sealy Center for Vaccine Development Country of Publication: England NLM ID: 101699863 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-0105 (Electronic) Linking ISSN: 20590105 NLM ISO Abbreviation: NPJ Vaccines Subsets: PubMed not MEDLINE